C. Ceylan Et Al. , "Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting [1]," American Journal of Hematology , vol.59, no.3, pp.260, 1998
Ceylan, C. Et Al. 1998. Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting [1]. American Journal of Hematology , vol.59, no.3 , 260.
Ceylan, C., KIRIMLI, Ö., AKARSU, M., ÜNDAR, B., & GÜNERİ, S., (1998). Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting [1]. American Journal of Hematology , vol.59, no.3, 260.
Ceylan, C. Et Al. "Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting [1]," American Journal of Hematology , vol.59, no.3, 260, 1998
Ceylan, C. Et Al. "Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting [1]." American Journal of Hematology , vol.59, no.3, pp.260, 1998
Ceylan, C. Et Al. (1998) . "Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting [1]." American Journal of Hematology , vol.59, no.3, p.260.
@article{article, author={C. Ceylan Et Al. }, title={Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting [1]}, journal={American Journal of Hematology}, year=1998, pages={260} }